Unified Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
21,719
+400
+2% +$27.3K 1.57% 17
2026
Q1
$1.38M Sell
21,319
-295
-1% -$20.8K 1.41% 17
2025
Q4
$1.45M Sell
21,614
-270
-1% -$18.2K 1.46% 16
2025
Q3
$1.6M Sell
21,884
-310
-1% -$20.6K 1.6% 14
2025
Q2
$1.15M Buy
22,194
+847
+4% +$48.2K 1.24% 20
2025
Q1
$1.36M Buy
21,347
+2,622
+14% +$152K 1.61% 15
2024
Q4
$895K Buy
+18,725
New +$960K 1.02% 30

Other funds holding HALO

Unified Investment Management's HALO Position: Q2 2026 in Review

Unified Investment Management increased its Halozyme (HALO) stake by 1.9% in Q2 2026, buying an estimated $27.3K and bringing the position to 21,719 shares worth $1.7M. The position accounts for 1.57% of the portfolio, ranked #17.

Unified Investment Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 169 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Unified Investment Management held 21,719 shares of Halozyme worth $1.7M as of Q2 2026.
  • Unified Investment Management bought 400 Halozyme shares in Q2 2026, an estimated $27.3K.
  • Halozyme made up 1.57% of Unified Investment Management's portfolio in Q2 2026, its #17 holding.
  • Unified Investment Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 169 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Unified Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.